ArticleLeukemia2015

Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry.

A G Dinmohamed et al.PubMed ↗Publisher ↗

No numbers read from the abstract.